Purpose To define the melanopsin and cone luminance retinogeniculate pathway contributions to photophobia in healthy controls and migraineurs. Methods Healthy controls and migraineurs were categorized according to the International Classification of Headache Disorders criteria. Photophobia was measured under full-field illumination using electromyography in response to narrowband lights spanning the melanopsin and cone luminance action spectra. Migraineurs were tested during their interictal headache-free period. Melanopsin-mediated post-illumination pupil responses quantified intrinsically photosensitive Retinal Ganglion Cell (ipRGC) function. Results A model combining the melanopsin and cone luminance action spectra best described photophobia thresholds in controls and migraineurs; melanopsin contributions were ∼1.5× greater than cone luminance. In the illumination range causing photophobia, migraineurs had lower photophobia thresholds (∼0.55 log units; p < 0.001) and higher post-illumination pupil response amplitudes ( p = 0.03) than controls. Conclusion Photophobia is driven by melanopsin and cone luminance inputs to the cortex via the retino-thalamocortical pathway. In migraineurs, lower photophobia thresholds reflect hypersensitivity of ipRGC and cone luminance pathways, with the larger and prolonged post-illumination pupil response amplitude indicative of a supranormal melanopsin response. Our findings inform artificial lighting strategies incorporating luminaires with low melanopsin excitation and photopic luminance to limit the lighting conditions leading to photophobia.

Glaucoma, a form of progressive optic neuropathy, is the second leading cause of blindness worldwide. Being a prominent disease affecting vision, substantial efforts are being made to better understand glaucoma pathogenesis and to develop novel treatment options including neuroprotective and neuroregenerative approaches. Cell transplantation has the potential to play a neuroprotective and/or neuroregenerative role for various ocular cell types (e.g., retinal cells, trabecular meshwork). Notably, glaucoma is often associated with elevated intraocular pressure, and over the past 2 decades, several rodent models of chronic ocular hypertension (COH) have been developed that reflect these changes in pressure. However, the underlying pathophysiology of glaucoma in these models and how they compare to the human condition remains unclear. This limitation is the primary barrier for using rodent models to develop novel therapies to manage glaucoma and glaucoma-related blindness. Here, we review the current techniques used to induce COH-related glaucoma in various rodent models, focusing on the strengths and weaknesses of the each, in order to provide a more complete understanding of how these models can be best utilized. To so do, we have separated them based on the target tissue (pre-trabecular, trabecular, and post-trabecular) in order to provide the reader with an encompassing reference describing the most appropriate rodent COH models for their research. We begin with an initial overview of the current use of these models in the evaluation of cell transplantation therapies.

We examined the contributions of rhodopsin and melanopsin to human brightness estimation under dim lighting. Absolute brightness magnitudes were estimated for full-field, rhodopsin-, or melanopsin-equated narrowband lights ( λ m a x : 462 , 499, 525 nm). Our data show that in scotopic illumination ( − 5.1 to − 3.9 log µ W a t t s ⋅ c m − 2 ), the perceptual brightness estimates of rhodopic irradiance-equated conditions are independent of their corresponding melanopic irradiance, whereas brightness estimates with melanopic irradiance-equated conditions increase with increasing rhodopic irradiance. In mesopic illumination ( − 3.4 to − 1.9 log µ W a t t s ⋅ c m − 2 ), the brightness estimates with both lighting conditions increase with increasing rhodopic or melanopic irradiances. Rhodopsin activation therefore entirely signals scotopic brightness perception and plateaus in mesopic illumination where intrinsic melanopsin contributions become first evident. We infer that all photoreceptor signals are transmitted to higher visual centers for representing scene brightness in scotopic and mesopic illumination through both conventional and melanopsin ganglion cell pathways.

No abstract

There was good agreement between GAT and other tonometers, but was not good enough for them to be used interchangeably. A combination of CH and CRF may better explain the variability between GAT and tonometers.